Determinants of the intima-media thickness in children and adolescents with chronic kidney disease

Pediatric Nephrology

Volumn 23, Issue 5, 2008, Pages 805-811

  Ziolkowska, Helena ^a   Brzewski, Michal ^a   Roszkowska Blaim, Maria ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Arterial changes; CAP CIP ratio; Chronic kidney disease; Fetuin A; Osteocalcin; Osteoprotegerin

Indexed keywords

ALFACALCIDOL; ALKALINE PHOSPHATASE; CALCIUM; CALCIUM CARBONATE; CHOLESTEROL; CYCLASE ACTIVATING PARATHYROID HORMONE; CYCLASE INHIBITING PARATHYROID HORMONE; FETUIN A; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LYASE; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CAROTID ARTERIOGRAPHY; CAROTID ARTERY DISEASE; CHILD; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER ECHOGRAPHY; ENZYME ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; LIPID BLOOD LEVEL; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; TREATMENT DURATION;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BLOOD PROTEINS; BONE DENSITY; CAROTID ARTERIES; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; LUMBAR VERTEBRAE; MALE; PERIPHERAL VASCULAR DISEASES; PHOSPHORUS; PROGNOSIS; RISK FACTORS; TIME FACTORS; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER;

EID: 41749088481     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0733-6     Document Type: Article

References (29)

1. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM (1998) Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 32:570-574
2. Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041-2047
3. Goodman WG, Goldin J, Kuizon BD, Yoon Ch, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
4. McDonald SP, Craig JC (2004) Long-term survival of children with end-stage renal disease. N Engl J Med 350:2654-2662
5. Groothoff JW, Gruppen MP, Offringa M, Hutten J, Lilien MR, Van De Kar NJ, Wolff ED, Davin JC, Heymans HS (2002) Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 61:621-629
6. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C (2001) Prognostic value of ultrasonographic measirement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12:2458-2464
7. Litwin M, Wühl E, Jourdan C, Trelewicz J, Niemirska A, Fahr K, Jobs K, Grenda R, Wawer ZT, Rajszys P, Troger J, Mehls O, Schaefer F (2005) Altered morphologic properties of large arteries in children with chronic renal failure and after renal transplantation. J Am Soc Nephrol 16:1494-1500
8. O'Leary DH, Polak JF, Kronmal RA, Mamolio TA, Burke GL, Wolfson SK Jr (1999) Carotid artery intima-media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 34:14-22
9. Nishizawa Y, Shoji T, Wagasue K, Okuno S, Kim M, Emoto M, Ishimura E, Nakatani T, Miki T, Inaba M (2003) Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 41 (3 Suppl 1):S76-S79
10. National Cholesterol Education Program (NCPEM) (1992) Highlights of the report of the expert panel on blood cholesterol level in children and adolescents. Pediatrics 89:495-501
11. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27:394-401
12. Guerin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021
13. Tamashiro M, Iseki K, Sunagawa O, Inoue T, Higa S, Afuso H, Fukiyama K (2001) Significant association between progression of coronary artery calcification and dyslipidemia in patients on chronic hemodialysis. Am J Kidney Dis 38:64-69
14. Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245-252
15. Braun J, Asmus HG, Holzer H, Brunkhorst R, Krause R, Schulz W, Neumayer HH, Raggi P, Bommer J (2004) Long-term comparison of calcium-free phosphate binder and calcium carbonate-phosphorus metabolism and cardiovascular calcification. Clin Nephrol 62:104-115
16. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB (1999) Clustering metabolic factors and coronary heart disease. Arch Intern Med 159:1104-1109
17. Jono S, McKee MD, Murry ChE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87:10-17
18. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers L, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM (2004) Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15:2857-2867
19. Kurz P, Monier-Faugere M-C, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855-861
20. Stompór T, Pasowicz M, Sułowicz W, Dembinska-Kiec A, Janda K, Wojcik K, Tracz W, Zdzienicka A, Klimeczek P, Janusz-Grzybowska E (2003) An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in ESRD patients treated with peritoneal dialysis. Am J Kidney Dis 41:203-211
21. Poyrazoǧlu HM, Dudie;şudie;nsel R, Yikilmaz A, Narin N, Anarat R, Gudie;ndudie;z Z, Coşkun A, Baykan A, Odie;ztudie;rk A (2007) Carotid artery thickness in children and young adults with end-stage renal disease. Pediatr Nephrol 22:109-116
22. Bucay N, Sarosi I, Dunstan CR, Marony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268
23. Jono S, Ikari Y, Shioi A, Mori K, Miki T, Hara K, Nishizawa Y (2002) Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106:1192-1194
24. Nitta K, Akiba T, Uchida K, Otsubo S, Takei T, Yumura W, Kabaya T, Nihei H (2004) Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant 19:1886-1889
25. Moe S, Reslerova M, Ketteler M, O'Neil K, Duan D, Koczman J, Westenfeld R, Jahnen-Dechent W, Chen NX (2005) Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD). Kidney Int 67:2295-2304
26. Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, Jankovic L, Manni M, Morosetti M, Moscaritolo E, Sarde D, Bonucci E (2002) Serum osteoprotegerin and renal osteodystrophy. Nephrol Dial Transplant 17:233-238
27. Kazama JJ, Omori K, Yamamoto S, Ito Y, Maruyama H, Narita I, Gejyo F, Iwasaki Y, Fukagawa M (2006) Circulating osteoprotegerin affects bone metabolism in dialysis patients with mild secondary hyperparathyroidism. Ther Apher Dial 10:262-266
28. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha2-Heremans-Schmid glycoprotein/fetuin A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357-366
29. Ketteler M, Bongartz P, Westenfeld R, Wildberger JE, Mahnken AH, Bodie;hm R, Metzger T, Wanner C, Jahnen-Dechent W, Floege J (2003) Association of low fetuin A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: A cross sectional study. Lancet 361:827-833